Wuhan Kangle Pharmaceutical

Wuhan Kangle Pharmaceutical Co., Ltd. is a modernized pharmaceutical company based in Wuhan, China, specializing in the research, development, production, and sales of traditional Chinese patent medicines (TCM) and chemical formulations. Founded in 1965 and formerly a subsidiary of Humanwell Healthcare (sold in 2024 to Shudu Medicine Technology), the company operates advanced manufacturing facilities that are GMP-certified for multiple dosage forms, including granules, syrups, tablets, capsules, and mixtures. Its product portfolio features prominent TCM products such as Jianganle Granules, Qinglin Granules, and Liangyuan Loquat Leaf Ointment, targeting therapeutic areas like hepatology, respiratory health, gynecology, and pediatrics. Wuhan Kangle Pharmaceutical also operates a highly automated intelligent decoction and distribution center in Central China, serving thousands of patients daily.